Noreen counsels pharmaceutical and medical device companies on a wide variety of FDA regulatory issues. She has in-depth knowledge of federal regulations governing the FDA application process, the conduct of clinical trials, product labeling, adverse event reporting and analysis, promotional claims, regulatory inquiries, and the external communication of medical information. In addition to her counseling practice, she assists clients with the preparation of SEC filings and conducts due diligence in conjunction with securities offerings and mergers and acquisitions. Her practice also includes the defense of pharmaceutical companies in civil and criminal actions and government investigations.
Firm News
05.09.22
Troutman Pepper Advises Apnimed in Series C Financing to Advance Development of Novel Pharmaceutical Treatments for Obstructive Sleep Apnea and Related Sleep Disorders
Firm News
10.22.21
Troutman Pepper Represents Cognition Therapeutics in Initial Public Offering
Firm News
08.13.21
Troutman Pepper Advises PharmaCyte Biotech on Follow-On Public Offering and Uplisting to Nasdaq
Firm News
06.22.21
Troutman Pepper Advises Inhibikase Therapeutics, Inc. on Follow-On Public Offering